New Data for BAVENCIO(R) (avelumab) for Advanced Cancers to Be...
DARMSTADT, Germany, and NEW YORK, Sept. 27, 2019 /PRNewswire-AsiaNet/ -- Analyses from the Phase III JAVELIN Renal 101 study support efficacy of BAVENCIO plus axitinib across multiple subgroups of patients with advanced renal cell carcinoma (RCC) Abstracts highlight data on BAVENCIO as a monotherapy and in combinat...
Authors: LATEST ASIANET NEWS RELEASES